BRCA1 and cancer: TP53 mutations are highly prevalent in TNBC, being present in almost all of these cancers.1 Approximately 10% of TNBC occur in patients harboring germline mutations in BRCA1, and additional subset of TNBC may harbor somatic mutations or epigenetic disruption of BRCA1 expression.